Results 271 to 280 of about 175,639 (315)
Some of the next articles are maybe not open access.

Studies on the Allergenicity of 5‐Fluorouracil

The Journal of Dermatologic Surgery and Oncology, 1977
A recent investigation has suggested that delayed hypersensitivity reactions commonly develop during topical 5‐FU therapy and imply that the mechanism of action of 5‐FU may involve destruction of actinic keratoses by a nonspecific immunological reaction.
J J, Leyden, A M, Kligman
openaire   +2 more sources

Effects of 5-Fluorouracil on mRNA

1993
Currently, there are a number of studies which suggest that FU can have pronounced effects on mRNA and its metabolism. However, the relevance of these changes to the antitumor effect of FU are still not clear. Generally, the mRNAs which have been studied to date involve those genes which are associated with the TS-directed effects of FU and have ...
B J, Dolnick, X P, Wu
openaire   +2 more sources

Bowen's disease and 5-fluorouracil

Journal of the American Academy of Dermatology, 1979
Sixty-six confirmed cases of Bowen's disease (intraepidermal squamous cell carcinoma) were seen from 1965 through 1976: twenty-four cases were treated surgically-four by excision (two recurrences) and twenty by desiccation and curettage (four recurrences); one was treated with x-ray radiation; and forty-one were treated with topical 5-fluorouracil (5 ...
openaire   +2 more sources

The mutation of poliovirus by 5-fluorouracil

Virology, 1964
Abstract Poliovirus grown in 4 m M 5-fluorouracil (5-FU) at an optimum temperature (36°) becomes more “heat defective”; that is, the ratio of plaques formed at supraoptimal temperatures to plaques formed at 36° (“plating efficiency”) is decreased by a factor of 3–10. The plating efficiency at an infraoptimal temperature (30°) is unchanged.
openaire   +2 more sources

5-Fluorouracil (FUra)

Pharmacology & Therapeutics, 1984
F, Valeriote, G, Santelli
openaire   +2 more sources

[5-fluorouracil].

Gan to kagaku ryoho. Cancer & chemotherapy, 2001
Many a dose and schedule of single agent of 5-fluorouracil (5-FU) has been evaluated to improve therapeutic outcome for four decades. No standard or an optimal dose and schedule has been established yet despite intensive clinical, investigation. Since 5-FU seems to have dual, mechanisms of cell kill; DNA and RNA directed cytotoxicity, it is important ...
openaire   +1 more source

Enhancement of the Effects of 5-Fluorouracil

1986
5-Fluorouracil (5-FU) is one of the few anticancer agents that has been developed on a rational basis [10]. Although it has been clinically used since the late 1950s, 5-FU has recently attracted new interest because of two developments: 1. Methods have been developed which allow the detection of small amounts of 5-FU and most of its metabolites.
openaire   +2 more sources

5-Fluorouracil

2007
Daniel B. Longley, Patrick G. Johnston
openaire   +2 more sources

5-Fluorouracil (z.B. 5-Fluorouracil „Ebewe“)

2002
Ines Mader   +5 more
openaire   +1 more source

5-Fluorouracil

Reactions Weekly, 2021
openaire   +1 more source

Home - About - Disclaimer - Privacy